TrialJournal of diabetes investigation2020

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study.

Li Xin Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.